adaptive biotechnologies ceo on partnership with microsoft to study coronavirus
Published 4 years ago • 1.9K plays • Length 7:16Download video MP4
Download video MP3
Similar videos
-
3:53
adaptive biotech is working to develop the best antibody treatment for covid-19: ceo
-
5:26
adaptive biotechnologies ceo on covid-19 research efforts, russia vaccine claims
-
6:18
adaptive biotechnologies ceo on the company's ipo and pipeline
-
3:15
adaptive biotech t-cell test receives fda approval for emergency use
-
1:02:22
covid-19 t-cell data: mapping out sars- cov-2 antigen & t-cell repertoires
-
1:07
adaptive biotechnologies doubles in public debut
-
3:10
how biotech firms plan to ensure diversity in covid-19 vaccine trials
-
5:46
labcorp ceo discusses covid-19 mutations
-
49:53
how to survive the 21st century | davos 2020
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
6:16
biotech dealmaking shows signs of life, says portal innovations ceo
-
7:48
study on coronavirus mutation doesn't prove new strain is more infectious: dr. scott gottlieb
-
37:08
founder stories: chad robins, co-founder and ceo of adaptive biotechnologies
-
2:11
adaptive biotechnologies’ immune medicine platform
-
5:56
elevation partners co-founder on the state of big tech
-
2:45
pioneers in immune medicine
-
4:51
top-ranked barron's advisor on investment strategies amid the coronavirus and market volatility
-
3:00
moderna ceo bancel: future covid vaccine booster will likely target omicron variant
-
2:36
abbott labs ceo: binaxnow is complementary to covid-19 vaccine campaign
-
1:13
immunecode chapter 1 – what the immune response can tell us about relevant antigens
-
6:00
do i need a covid booster? will it protect against the omicron variant?
-
2:18
nine biopharma ceos pledge to make safety the main focus in covid-19 vaccine development